Compare Align Technology, Inc. (ALGN) vs Macy's Inc (M) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Align Technology, Inc. vs Macy's Inc — how do they compare? Align Technology, Inc. trades at $182.11 (market cap $12.86B), while Macy's Inc trades at $22.98 (market cap $5.96B). The key difference: Align Technology, Inc. is far larger — about 2.2× Macy's Inc's market cap, and Macy's Inc pays a 3.38% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | M | |
|---|---|---|
Market Cap | $12.86B | $5.96B |
Sector | Health | Consumer Cyclical |
52-Week High | $207.19 | $25.96 |
52-Week Low | $124.88 | $11.90 |
Enterprise Value | $11.92B | $9.77B |
Dividend Yield | — | 3.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Macy's (M) trades at $22.64, down 0.18% on the day, with a bullish technical signal and strong recent earnings beats. The stock shows attractive valuation metrics including a P/E of 9.36 and P/S of 0.27, while profitability metrics like ROE of 14.36% indicate efficient capital use. Recent news highlights Berkshire Hathaway's new 3.04 million-share stake and the company's 'Bold New Chapter' strategy driving comparable sales growth.
The outlook for Macy's is cautiously optimistic with a consensus price target of $24.83 offering ~10% upside. Key opportunities include luxury brand expansion and digital transformation, while risks involve margin pressure from restructuring and competitive retail headwinds. The stock presents a value opportunity if turnaround execution continues successfully.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Macy's Inc
Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.
Read more on M →
